Stokes Family Office’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,246
Closed -$48K 287
2022
Q1
$48K Buy
+15,246
New +$48K 0.01% 256